Epsolin ER 300 Tablet contains Phenytoin 300mg, an antiepileptic medication primarily used to control generalized tonic-clonic (grand mal) and complex partial seizures. Phenytoin acts by stabilizing neuronal membranes and decreasing seizure activity by increasing efflux or decreasing influx of sodium ions across cell membranes in the motor cortex during the generation of nerve impulses. Epsolin ER 300 is an extended-release formulation designed to maintain steady plasma concentrations, thereby improving seizure control and enhancing patient compliance by reducing dosing frequency. It is indicated for the management of epilepsy and prevention of seizures following neurosurgery or head trauma. Dosage should be individualized based on patient response and serum phenytoin levels, with careful monitoring to avoid toxicity. Common adverse effects include dizziness, ataxia, nystagmus, and gingival hyperplasia, while serious reactions may involve hypersensitivity, hepatotoxicity, and hematologic abnormalities. Caution is advised in patients with hepatic impairment, cardiac conditions, or hypersensitivity to phenytoin. Drug interactions are significant, as phenytoin induces hepatic enzymes and may alter the metabolism of concomitant medications. Regular monitoring of therapeutic levels and clinical status is essential to optimize efficacy and minimize adverse effects. Epsolin ER 300 should be used under strict medical supervision.